FDA Approved: CUVPOSA — Original Application (Merz Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for CUVPOSA (glycopyrrolate) from Merz Pharmaceuticals, LLC, under NDA 022571. It is approved for the treatment of sialorr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Sialorrhea

Drugs mentioned

• CUVPOSA (glycopyrrolate)

Snippet

ORIG AP for CUVPOSA (GLYCOPYRROLATE)